Plasma atrial natriuretic peptides in the horse and goat with special reference to exercising horses by Kokkonen, Ulla-Maija
PLASMA ATRIAL NATRIURETIC PEPTIDES IN THE HORSE
AND GOAT WITH SPECIAL REFERENCE TO EXERCISING
HORSES
Ulla-Maija Kokkonen
Helsinki 2002
Faculty of Veterinary Medicine
Department of Basic Veterinary Sciences
University of Helsinki
and
National Veterinary and Food Research Institute
Helsinki
Finland
PLASMA ATRIAL NATRIURETIC PEPTIDES IN THE HORSE
AND GOAT WITH SPECIAL REFERENCE TO EXERCISING
HORSES
Ulla-Maija Kokkonen
Academic Dissertation
to be presented with the permission of the Faculty of Veterinary Medicine of the University of Helsinki,
for public criticism in Auditorium Maximum, Hämeentie 57, 00580 Helsinki,
on the 22nd of  March, 2002, at 12 noon.
Helsinki 2002
ISBN  952-91-4419-9 (nid.)
ISBN  952-10-0387-1 (verkkojulkaisu, pdf)
http://ethesis.helsinki.fi
Helsinki 2002
Yliopistopaino
                                                                                                                         to     Hanna
                                                                                 Markku
                                                                               Minna

CONTENTS
1. Abstract 1
2. List of original publications 3
3. Abbreviations 4
4. Introduction 5
5. Review of the literature 7
5.1 Atrial natriuretic peptide 7
5.1.1 Cardiac peptide hormones and their function 7
5.1.2 Structure and biosynthesis 7
5.1.3 Storage in cells and tissue distribution 10
5.1.4 Release 11
5.1.5 Circulating peptides and their biological activity 13
5.1.6 Receptors of natriuretic peptides 13
5.1.7 Metabolism 14
5.1.8 Plasma levels 15
5.1.9 Circadian rhythm 16
5.2 Exercising horse 16
5.2.1 Horse breeds and interbreed differences 16
5.2.2 Types of exercise and exercise testing 17
5.2.3 Cardiovascular responses 17
5.2.4 Blood volume expansion 19
5.2.5 Hormonal responses 19
5.2.6 Thermoregulation and water balance 20
5.2.7 Training 21
5.2.8 Apprehension and anxiety 21
5.2.9 Recovery 22
6. Aims 23
7. Materials and Methods 24
7.1 Animals 24
7.2 Experimental procedures 25
7.2.1 Exercise tests 25
7.2.1.1 Submaximal graded exercise test
(Standardised Exercise Test = SET) 25
7.2.1.2 Endurance exercise test with varying velocities
(Competition Exercise Test = CET) 25
7.2.1.3 Submaximal steady state exercise tests 25
7.2.1.4 Duration of exercise and exercise distances 26
7.2.2 Experiments on circadian changes 26
7.2.3 Samples 26
7.2.4 Other measurements 27
7.3 Analytical procedures 28
7.3.1 Blood and urine analysis 28
7.3.2 Statistical analysis 29
8. Results 29
8.1 Plasma ANP and NT-ANP levels 29
8.2 Responses to exercise 29
8.2.1 Plasma ANP in Standardbreds and Finnhorses during and after
exercise (Study I) 29
8.2.2 Atrial peptides in relation to neuroendocrine  responses and fluid
balance (Study II) 30
8.2.3 Atrial peptides during and after repeated exercise under heat
exposure (Study III) 31
8.2.4 Plasma ANP in relation to hydration status and exercise intensity
(Study IV) 32
8.2.5 Effect of exercise type on plasma ANP and NT-ANP concentrations
(Studies I-IV) 32
8.2.6 Atrial peptides in relation to heart rate, treadmill speed, workload,
and duration of exercise (Studies I-IV) 34
8.2.7 Plasma ANP in relation to physical condition (Studies I-II) 36
8.3 Cyclic changes 37
8.3.1 Daily variation in ANP in horses (Study III) 37
8.3.2 Circadian variation in ANP, cortisol and fluid balance in goats (Study V) 37
9. General discussion 37
9.1 Plasma ANP and NT-ANP levels in horses and goats (I-V) 37
9.2 Changes in plasma ANP and NT-ANP in horses during exercise
(I-IV) 39
9.3 Changes in plasma ANP and NT-ANP in horses after exercise (I-IV) 41
9.4 On factors associated with changes in plasma atrial peptides 42
9.4.1 Heart rate (I-IV) 42
9.4.2 Blood volume expansion (I, II, IV) 43
9.4.3 Hormones (II, III) 44
9.4.4 Heat exposure (III) 45
9.4.5 Fluid balance (II-IV) 45
9.4.6 Exercise intensity (I-IV) 46
9.4.7 Training (I-IV) 46
9.4.8 Circadian changes (III, IV) 47
10. Conclusions 49
11. Acknowledgements 51
12. References 53
11. Abstract
Atrial natriuretic peptides, the COOH-terminal ANP99-126 (ANP), and the NH2-terminal
NT-ANP1-98 (NT-ANP), the two fragments of the atrial natriuretic propeptide ANP1-126
were studied. ANP is regarded as a physiological regulator because of its vascular
and renal effects, and its plasma concentration has been observed to increase on
any occasion that strains the heart. It is well known that physical activity accelerates
cardiovascular function and upsets fluid balance. To increase knowledge of atrial
peptides and their responses to exercise in the horse, a species characterized as an
extreme animal athlete, exercise tests on a treadmill were carried out in 37 horses. In
addition, since cyclic changes are known to exist in physiological phenomena, and
the previous results on circadian changes obtained in human subjects and rats have
been contradictory, circadian variation in ANP was examined in two quadruped
species, the horse and the goat, both of which represent species in which postural
effects on ANP were expected to be minor.
The results confirmed that atrial peptides are released in horses in response to
exercise. Increasing heart rate and work intensity, as well as the volume expansion
known to increase atrial pressure, together with the functioning of the muscular and
respiratory pumps were shown to have a contributory influence on these responses.
Of the endocrine factors, noradrenaline was correlated with ANP at the start of
exercise and may contribute to release of atrial peptides in exercising horses, directly
or indirectly. The role of  other pressor hormones during submaximal exercise
appeared, however, to be small. Exercise-induced responses in ANP were
modulated by water balance and physical condition. Standardizing the test according
to heart rate response, however, abolished the effect of physical condition. Taken
together, these results agree well with the theory that atrial stretch is the main
determinant of atrial peptide release during acute stimulation
The temporal patterns in plasma ANP and NT-ANP differed, most probably due to
differences in their plasma half-lives. NT-ANP was shown to be more stable in
plasma than was ANP and can thus be useful in horses as an indicator of changes in
plasma atrial peptides.
2After exercise, plasma concentrations of atrial peptides returned slowly to their pre-
exercise levels, in contrast to changes reported previously in human subjects. The
temporal patterns of ANP and NT-ANP indicate that their release remained
stimulated even after completion of exercise. Blood volume expansion, the
respiratory pump, and heart rate partially explained these changes; the role of
vasoactive hormones seemed to be minor. Intensity of exercise and changes in water
balance were observed to modulate recovery of atrial peptides.
In the horse and the goat, plasma ANP levels were individual, ranging at rest from 1
to 10 pmol/l. Basal plasma NT-ANP concentration was 45-fold higher than in ANP,
being in horses from 200 to 300 pmol/l. Basal plasma concentrations of ANP and NT-
ANP were affected neither by breed nor by physical condition, but in relation to
gender, the lower plasma concentrations occured in stallions. Circadian changes in
ANP in physically inactive animals were minor, providing no evidence for circadian
variation in plasma ANP.
In conclusion, the present results imply that ANP is a factor involved in regulation of
cardiovascular control and fluid balance during and after exercise in horses.
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43. Abbreviations
ACTH adrenocorticotropic hormone / adrenocorticotrophin / corticotrophin
ADH antidiuretic hormone / AVP
ANF atrial natriuretic factor / ANP
ANP ANP99-126  / the COOH-terminus of the prohormone ANP1-126 / atrial
natriuretic peptide / A-type natriuretic peptide / ANF
ANPA guanylate cyclase receptor mediating the effects of ANP and BNP
ANPB guanylate cyclase receptor mediating the effects of CNP
ANPC clearance receptor of atrial peptides
ANOVA analysis of variance
AVP arginine vasopressin / vasopressin / ADH
BNP brain natriuretic peptide / B-type natriuretic peptide
bpm beats per minute
CET competition exercise test / 60-min exercise with varying velocities
cGMP guanosine 3’,5’-monophosphate
CNP C-type natriuretic peptide
EDTA ethylenediaminetetraacetic acid
EXP 1 40-min steady-state exercise test at 65-70% of HRmax
EXP 2 12-min steady state exercise test at 90% of HRmax
HPLC high-performance liquid chromatography
HRmax maximal heart rate
NT-ANP NT-ANP1-98 , NH2-terminus of the prohormone ANP1-126
PCV packed cell volume / haematocrit value
RIA radioimmunoassay
SET standardised exercise test / 8- or 6-min exercise test with graded velocities
54. Introduction
The electron-microscopic studies in the 1950s and in the 1960s showed that
mammalian heart atria contained storage granules which morphologically resembled
secretory granules in endocrine cells (Kisch 1956, Jamieson & Palade 1964). Later
on, it was shown that the granularity varied in situations of altered water-electrolyte
balance (de Bold 1979). The secretory function of the atria did not become apparent
until 1981 when de Bold with his colleagues demonstrated that atrial homogenate
induced a massive, rapid diuresis and natriuresis in rats (de Bold et al. 1981). Soon
after these findings, the relationship between atrial granularity and the natriuretic
factor was confirmed (de Bold 1982), and the structure of the first peptide of the
natriuretic family, atrial natriuretic peptide (ANP), was characterized (Flynn et al.
1983). Further studies showed that ANP plays a physiological role in body fluid and
cardiovascular homeostasis by eliciting natriuresis, diuresis, reduction in plasma
volume and in blood pressure, and inhibition of the release and action of other
hormones. Other natriuretic peptides closely related to ANP have been identified
subsequently. Active research and new analytical methods, especially
radioimmunological assays, introduced first in the1960s (Yalow 1960), and methods
based on molecular and cellular biology have had a decisive effect on the
development of our understanding of cardiac endocrinology. Consequently, today, it
goes without saying that, besides the contractile function, the mammalian heart also
possesses an endocrine role by releasing physiologically active compounds into the
circulation.
Physical activity strains the heart by increasing the cardiac work load. This occurs as
a part of cardiovascular readjustment in order to supply the increased metabolic
demands during exertion. Some previous results have shown that physical activity
raises plasma ANP concentration in horses (McKeever et al. 1991a, b) and in goats
(Kokkonen 1992). Considering the physiological effects of exogenously administered
ANP: reduction in heart rate, stroke volume, cardiac output and blood pressure, as
well as modulation of capillary filtration capacity, it is quite possible that ANP
contibutes to adaptive changes in cardiovascular stress, for example, through
regulation of blood flow. Among the animal models of exercise, the horse represents
a species that can be regarded as a native athlete. Its respiratory and circulatory
functions, e.g., oxygen uptake, delivery, and supply, as well as blood composition,
6are specialized for exercise, endowing the horse with an excellent aerobic
performance capacity (Erickson 1993). These are phenomena distinguishing the
horse from ”sedentary” species, such as ruminants (Hoppeler 1990), and also from
humans. Despite the marked increase in understanding of equine exercise
physiology during the past ten years, more systematical research is required for a full
description of atrial peptides as well as their interaction with cardiovascular and
endocrine systems in horses. Although the overall knowledge of the whole natriuretic
peptide family at present is wide, in horses, identification of these peptides, their
release mechanisms, metabolism, function, and physiological importance are still to a
great extent unknown.
To increase knowledge of atrial peptides in the horse, the experiments for this study
were begun in 1992 as part of a new approach to equine cardiac endocrinology, to
investigate effects of physical stress on plasma ANP, the COOH-terminal ANP99-126,
and NT-ANP, the NH2-terminal NT-ANP1-98, which are the two cleavage products of
the prohormone ANP1-126, until now the only natriuretic peptide identified in the horse.
These responses were further assessed in relation to physiological factors  known or
expected to be involved in release of atrial peptides. It was also of interest to
determine basal plasma level of ANP in the horse and to compare it with that in
another quadruped species, here the goat. Knowing that circadian rhythm affects
plasma levels of many hormones, it was important to learn more about circadian
changes in ANP. While most of the studies have described circadian changes in ANP
in humans and other plantigrades, the present study shows these changes in two
quadruped species, adapted to living permanantly in a horizontal posture. Contrary to
humans, the greatest part of the blood volume in quadrupeds exists at the level of the
heart or above it, but it is unclear whether this has any importance in regulation of
atrial peptides in those species.
75. Review of the literature
5.1 Atrial natriuretic peptide
5.1.1 Cardiac peptide hormones and their function
Atrial natriuretic peptide (ANP, also called A-type natriuretic peptide, ANF, atrial
natriuretic factor, atriopeptin, auriculin, cardiodilatin, and cardionatrin) and brain
natriuretic peptide (BNP or B-type natriuretic peptide, named for the tissue in which it
was first discovered) are two rather  well-known cardiac natriuretic polypeptides in
mammals (for references, see Ruskoaho 1992, Nakao et al. 1992). Contrary to ANP,
which is released from the atria, BNP is synthesized and secreted mainly by the
ventricle (Nakao et al. 1992). The C-type natriuretic peptide (CNP), a structurally
homologous peptide with the A- and B-type peptides, is the third gene product of the
natriuretic family, but its major sites of synthesis are in vascular endothelial cells and
the central nervous system, and it has been considered a paracrine regulator rather
than a cardiac peptide (Minamino et al. 1991, Ogawa et al. 1995). Another hypotensive
peptide, adrenomedullin, initially isolated from human pheochromocytoma cells
(Kitamura et al. 1993), is also considered nowadays a cardiac hormone. In addition,
other cardiac hormones, such as the salmon cardiac hormone (Tervonen et al. 1998),
have been recently discovered.
The main effects of ANP and BNP include natriuresis, diuresis, vasodilatation,
reduction in blood pressure and in plasma volume, inhibition of biosynthesis, and
release and action of other hormones, such as those of the renin-angiotensin-
aldosterone system, and of endothelin and AVP (Atlas & Laragh 1987, Charles et al.
1990,1993, 1996, Rosenzweig & Seidman 1991, Ruskoaho et al. 1997). Most of the
biological functions of natriuretic peptides are mediated by intracellular accumulation
of guanosine 3’,5’-monophosphate (cGMP) through the activation of a particulate
guanylyl cyclase (Hamet et al. 1984).
5.1.2 Structure and biosynthesis
The structure of ANP has been elucidated following cloning and sequencing of the
complementary DNA and genes encoding ANP. The ANP gene is organised into
three exons separated by two introns (Nakao et al. 1992, Ruskoaho 1992).
8Transcription of  the gene yields a messenger RNA that encodes a precursor
molecule, preproANP, which contains between 149 and 153 amino acids depending
upon the species (for references, see Nakao et al. 1992 and Ruskoaho 1992, Richter
et al. 1998). PreproANP is cleaved in the endoplasmic reticulum by endoprotease
into a signal peptide and into the126-residue-containing prohormone ANP1-126, also
called proANP. ProANP remains uncleaved under transport and is stored in this
inactive form in the atrial cardiocytes (Forssmann et al. 1983, 1984, Thibault et al.
1987, Richter et al. 1998). This has been regarded as an unique character of  ANP,
because several other peptide hormones are processed during transport and in
secretory granules, and are stored as bioactive hormones (Ruskoaho 1992).
Biosynthesis of BNP, a distinct gene product, resembles that of ANP with the
exception that the storage form in the heart is the cleaved mature form (Nakao et al.
1992).The amino acid sequence of proANP, comprising a molecule with molecular
weight approximately 13 000, is well conserved among mammals (Kangawa et al.
1985, Ruskoaho 1992). Upon appropriate stimulus, proANP is cleaved into the
COOH-terminal peptide, ANP99-126, and NH2-terminal peptide, NT-ANP1-98, also called
NT-ANP (Thibault et al. 1985, Michener et al. 1986). This conversion occurs close to
the myocyte itself and almost simultaneously with secretion, probably by a serine
protease, although some other enzymes may be involved as well (Inagami et al.
1989, for references, see Ruskoaho 1992).
The biologically active ANP is a 28-amino acid peptide with a ring structure formed
by an intramolecular disulfide linkage between cysteine residues due to post-
translational modification, and has a molecular weight of approximately 3000
(Kangawa et al. 1985). Its amino acid sequence is highly conserved in mammalian
species, except for a single amino acid  residue at the 12th position which is
methionine in most mammalian species but isoleucine in the rat, mouse, and rabbit
(Table 1). Richter et al. (1998) have reported the amino acid sequence of equine
ANP (Table1). The amino acid sequence of goat ANP has not been determined;
however, the results in other ruminants (Vlasuk et al. 1986, Charles et al. 1990,
Yandle et al. 1991, Aitken et al. 1999) suggest that also the amino acid sequence of
caprine ANP may be homologous with that in other mammalian species.
9BNP is closely related to ANP, as it also contains a carboxyl terminus with a 17-
residue ring  formed by a disulfide bond. In contrast to ANP, BNP is less homologous
across species (Maekawa et al. 1988, Kojima et al. 1989, Seilhamer et al. 1989,
Ogawa et al. 1994, Aitken et al. 1999). The structure of BNP in horses and goats has
not been documented. However, porcine BNP-26 immunoreactivity, but not that of
human BNP-32, has been shown in the auricular cardiocytes in horses (Mifune et al.
1995).
Table 1. Comparison of the COOH- terminal ANP1-28 sequences between various
species (Flynn et al. 1983, Forssmann et al. 1984, Kangawa and Matsuo 1984,
Seidman et al. 1984, Oikawa et al. 1985, Ong et al. 1986, Vlasuk et al. 1986,
Yandle et al. 1991, Richter et al. 1998, Aitken et al. 1999).
The mammalian NT-ANP contains 98 amino acids and is well conserved (Table 2).
For example, the sequence in sheep shows 71%, 75%, and 79% homology with the
sequences from humans, pigs, and cows, respectively (Aitken et al. 1999), and that
of equine NT-ANP 80 to 90% with the sequences from humans, cows, rats and mice
(Vlasuk et al. 1986, Richter et al. 1998). The most marked differences in the
sequences are in amino acids from 1 to 70 (Table 2). The length of the N-terminal
extension of BNP differs from that of ANP, consisting of 108, 106, 105, and 96 amino
acids in humans, pigs, dogs, and rats, respectively (Seilhamer et al. 1989).
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Human Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Dog Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Horse Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Sheep Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Cow Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Pig Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Rat Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Ile Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Mouse Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Ile Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
Rabbit Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Ile Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly
S - S 23 24 25 26 27 28
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
Cys Asn Ser Phe Arg Tyr
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Table 2. Comparison of the NH2-terminal ANP1-98 sequences between various
species (Oikawa et al. 1985, Vlasuk et al. 1986, Richter et al. 1998).
The structure of ANP in nonmammalian species, both COOH- and NH2-termini, differ
considerably from those in mammals (for references, see Ruskoaho 1992). In
chicken heart, the major natriuretic petide is a BNP-type peptide (Akizuki et al. 1991).
5.1.3 Storage in cells and tissue distribution
Cardiocytes of various animal species contain osmophilic granules with a remarkable
degree of ultrastructural and cytochemical similarities (Jamieson & Palade 1964,
Tomisawa 1969, Cantin et al. 1979). Their role as cardiac natriuretic peptide-
containing granules has been established in humans, in rodents (de Bold 1982, Flynn
et al. 1983, Forssmann et al. 1984, Kangawa & Matsuo 1984, Kangawa et al. 1985),
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Human Asn Pro Met Tyr Asn Ala Val Ser Asn Ala Asp Leu Met Asp Phe Lys Asn Leu Leu Asp His Leu
Dog Asn Pro Val Tyr Gly Ser Val Ser Asn Ala Asp Leu Leu Asp Phe Lys Asn Leu Leu Asp Arg Leu
Horse Asn Pro Val Tyr Gly Ser Val Ser Asn Gly Asp Leu Met Asp Phe Lys Asn Leu Leu Asp Arg Leu
Cow Asn Pro Val Tyr Gly Ser Val Ser Asn Ala Asp Leu Met Asp Phe Lys Asn Leu Leu Asp Arg Leu
Rat Asn Pro Val Tyr Ser Ala Val Ser Asn Thr Asp Leu Met Asp Phe Lys Asn Leu Leu Asp His Leu
23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44
Human Glu Glu Lys Met Pro Leu Glu Asp Glu Val Val Pro Pro Gln Val Leu Ser Asp Pro Asn Glu Glu
Dog Glu Asp Lys Met Pro Leu Glu Asp Glu Ala Glu Ser Pro Gln Ala Leu Ser Asp Gln Asn Ala Glu
Horse Glu Glu Lys Met Pro Leu Glu Asp Glu Val Met Pro Pro Gln Val Leu Ser Asp Gln Ser Glu Glu
Cow Glu Asp Lys Met Pro Leu Glu Asp Glu Ala Val Pro Ser Gln Val Leu Ser Glu Gln Asn Glu Glu
Rat Glu Glu Lys Met Pro Val Glu Asp Glu Val Met Pro Pro Gln Ala Leu Ser Glu Gln Thr Asp Glu
45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
Human Ala Gly Ala Ala Leu Ser Pro Leu Pro Glu Val Pro Pro Trp Thr Gly Glu Val Ser Pro Ala Gln
Dog Ala Gly Ala Ala Leu Ser Pro Leu Pro Glu Val Pro Pro Trp Thr Gly Glu Val Ser Pro Ala Gln
Horse Glu Arg Ala Ala Leu Ser Pro Leu Pro Glu Val Pro Pro Trp Thr Gly Glu Val Asn Pro Ala Gln
Cow Ala Gly Ala Pro Leu Ser Pro Leu Ser Glu Met Pro Pro Trp Met Gly Glu Val Asn Pro Ala Gln
Rat Ala Gly Ala Ala Leu Ser Ser Leu Pro Glu Val Pro Pro Trp Thr Gly Glu Val Asn Pro Ser Gln
67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88
Human Arg Asp Gly Gly Ala Leu Gly Arg Gly Pro Trp Asp Ser Ser Asp Arg Ser Ala Leu Leu Lys Ser
Dog Arg Asp Gly Gly Ala Leu Gly Arg Ser Pro Trp Asp Ser Ser Asp Arg Ser Ala Leu Leu Lys Ser
Horse Arg Asp Gly Gly Ala Leu Gly Arg Gly Ser Trp Asp Ser Ser Asp Arg Ser Ala Leu Leu Lys Ser
Cow Arg Glu Gly Gly Val Leu Gly Arg Gly Pro Trp Glu Ser Ser Asp Arg Ser Ala Leu Leu Lys Ser
Rat Arg Asp Gly Gly Ala Leu Gly Arg Gly Pro Trp Asp Pro Ser Asp Arg Ser Ala Leu Leu Lys Ser
89 90 91 92 93 94 95 96 97 98
Human Lys Leu Arg Ala Leu Leu Thr Ala Pro Arg
Dog Lys Leu Arg Ala Leu Leu Ala Ala Pro Arg
Horse Lys Leu Arg Ala Leu Leu Ala Ala Pro Arg
Cow Lys Leu Arg Ala Leu Leu Thr Ala Pro Arg
Rat Lys Leu Arg Ala Leu Leu Ala Gly Pro Arg
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and in domestic animals (Hinze et al. 1989, Mifune et al. 1991, 1995, 1996, Richter et
al. 1998). Atrial granules have been found all over the sarcoplasma (Tomisawa
1969), but those containing ANP are located principally in the perinuclear area of the
cells (Mifune et al. 1991, Ruskoaho 1992). Immunohistochemical and
immunoelectron microscopical studies have shown differences in the distribution and
average diameter of ANP immunoreactive granules, since their number and diameter
seem to be smaller in the horse than in the pig and cattle (Mifune et al. 1991). Similar
polymorphism has already been found in the early histological studies on atrial
granularity (Jamieson & Palade1964, Tomisawa 1969). The functional significance of
these differences remains unexplained.
In adult mammals, the ANP immunoreactive granules concentrate mainly in the
cardiocytes of the atria, whereas in fetuses and newborns they have been found in
both the atria and ventricles (for references, see Ruskoaho 1992). ANP-specific
mRNA, and proANP- and ANP-like immunoreactivity have also been shown in many
other tissues, e.g., aortic arch, lung, central nervous system, adrenal, corpus luteum,
skin, kidney, gastrointestinal tract, thymus, chorioidea and ciliary body, pancreas,
thyroid gland, spleen, testis, liver, salivary gland, lacrimal gland, and fowl salt gland
(for references, see Ruskoaho 1992). However, the ANP levels in these tissues are
unlikely to cause significant changes in plasma concentrations, because, in
physiological conditions, they have been far lower than those in the atrial cells (for
references, see Gutkowska & Nemer 1989). ANP-like peptides and their precursors
have been described  in hearts of nonmammalian species, but, in them, interspecies
differences seem to be considerable (for references, see Ruskoaho 1992, Mifune et
al.1996).
5.1.4 Release
ANP and BNP are released continuously from the heart, but the rate of the release
increases in response to appropriate stimuli. The reviews by Ruskoaho (1992), de
Bold et al. (1996), Ruskoaho et al. (1997), and Thibault et al. (1999) have described
a number of factors associated with plasma ANP level or stimulation of ANP
secretion from the heart. These include:
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1.   STRETCHING OF MYOCYTES
      volume expansion, sodium intake, water deprivation, haemorrhage, water immersion, posture
2.   INTRACELLULAR- AND ENDOTHELIUM–DERIVED FACTORS
      cationic environment (Ca2+), Na-K-ATPase inhibitors, endothelin, nitric oxide, prostaglandins
3.   HEART RATE
4.   NEUROHUMORAL AND OTHER  ENDOCRINE FACTORS
      adrenaline, noradrenaline, acetylcholine, vasopressin, glucocorticoids, thyroid hormone, angiotensin II,
      opiates
5.   PERIPHERAL AND CENTRAL NERVOUS SYSTEM
6.   OSMOLALITY
7.   HYPOXIA AND HYPERCAPNIA
8.   MYOCARDIAL ISCHEMIA AND METABOLIC CHANGES
9.   OTHER FACTORS
      age, circadian variation, exercise, heat exposure, cold
Regulation of the release of atrial peptides seems to be complex, since experimental
results thus far imply that endocrinologically the heart responds to different
haemodynamic challences in acute, subacute, and chronic conditions with specific
changes in transcription, translation, post-translational processing, storage, and
release of ANP and BNP (de Bold et al. 1996). Although the principles of the release
are fairly well known nowadays, the exact cellular mechanism resulting in
augmentation of the release of ANP and BNP has not been settled.
Myocyte stretch is regarded as the central regulator of ANP and BNP secretion
(Ruskoaho 1992, de Bold et al. 1996, Ruskoaho et al. 1997). Recent results have
provided evidence that the mechanisms controlling ANP release may, however, be
more complex, and the action of wall stretch may also occur via endogenous
paracrine and autocrine vasoactive factors such as endothelin-1, nitric oxide, and
angiotensin II (Ruskoaho et al. 1997).
Earlier experiments in vivo and in vitro have provided evidence that tachycardia
stimulates ANP secretion from the heart (for references, see Ruskoaho 1992), but
there are also experimental findings opposing its role as a primary stimulator of ANP.
These include, for example, the fact that increased heart rate in vivo is generally
accompanied by haemodynamic changes which may explain the ANP release.
Further, some studies have shown that pacing the heart does not increase ANP
release, and that ANP levels can be increased under experimental conditions in
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which atrial tension develops concomitantly with inhibition of beating (for references,
see Ruskoaho 1992, de Bold et al. 1996).
5.1.5 Circulating peptides and their biological activity)
Results of studies in vitro and in vivo have shown that ANP and NT-ANP are co-
secreted and released in equimolar amounts into the circulation (Itoh et al. 1988, for
references, see Ruskoaho 1992). The major circulating peptides derived from
proANP1-126 are NT-ANP1-98 and ANP99-126. ANP is the biologically active hormone,
whereas it is widely accepted that the NH2-terminus of ANP does not show biological
activity (for references, see Ruskoaho 1992). However, some studies have
suggested that smaller fragments derived from human NT-ANP circulate and have
diuretic and natriuretic effects, for example proANP31-67 in humans (Vesely et al.
1994), rats (Martin et al. 1990), dogs (Habibullah et al. 1995), and monkeys
(Benjamin & Peterson 1995). The results of the laboratory that first isolated and
chemically characterised the fragments of proANP1-126 do not support this latter view
(Weir et al. 1994).
5.1.6 Receptors of natriuretic peptides
Specific ANP-binding sites have been reported in various organs such as endothelial
cells, vascular smooth muscle cells, inner medullary collecting duct cells, and in
organs such as the lung, kidney, adrenal gland, liver, and intestine (for reviews, see
Gerbes & Vollmar 1990, Maack 1992). Three different receptor isoforms exist for the
natriuretic peptides ANPA (GCA, NPR-A or NP-A), ANPB (GCB, NPR-B or NP-B), and
ANPC (NPR-C). The ANPA and ANPB receptors are single transmembrane types and
are particulate guanylate cyclases (Inagami et al. 1995).  ANPA receptors are
important in mediating the physiological effects of ANP and BNP, whereas CNP acts
via ANPB receptors to affect vascular cell growth and remodelling (Inagami et al.
1995). The results of Leskinen et al. (1997) suggest further that ANP may modulate
its own release by ANPA receptors in vivo. ANPC receptors, which are not gualylate
cyclases, are responsible for clearance of atrial peptides from the circulation, and, in
this manner, play a role in the homeostasis of the circulating peptide level (Almeida
et al. 1989, Suga et al. 1992). The binding affinity of cardiac peptides to ANPC
receptors, reported in humans and rats, is as follows: ANP>CNP>BNP (Suga et al.
1992). In kidney (glomeruli), lung membranes, adrenal zona glomerulosa cells, and
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bovine aorta endothelial cells, the majority of ANP receptors seems to be ANPC
receptors (Gerbes & Vollmar 1990). Evidence exists that manipulations that alter
blood volume and pressure also alter plasma ANP levels and ANPC receptor density.
Many findings support the theory that a decreased number of ANPc binding sites
results in an increase in plasma ANP concentration, and in a relatively greater
amount of ANP binding to ANPA receptors (for references, see Ruskoaho 1992).
5.1.7 Metabolism
Receptor-mediated binding, uptake, and metabolism in target tissues, degradation by
enzymes and other processes at plasma membranes, and excretion, for example,
into urine may be involved in ANP clearance from the circulation (Ruskoaho 1992).
The major mechanisms for ANP clearance are uptake by clearance receptors and
enzymatic degradation by neutral endopeptidase (endopeptidase EC 3.4.24.11, also
called encephalinase and atriopeptidase) or some other enzymes (Gerbes & Vollmar
1990, Ruskoaho 1992). Various organs such as the lung, liver, intestine, and kidney,
as well as the limbs, contribute to clearance of atrial peptides from the circulation
(Hollister et al. 1989, Gerbes & Vollmar 1990). A general arterio-venous organ
extraction ratio for ANP has been reported to be about 35%. The blood flow in
different organs is variable and determines the contribution of these organs to the
total body clearance of atrial peptides (Gerbes & Vollmar 1990). For NT-ANP, the
kidney may be the major site of degradation (Katsube et al. 1986, Itoh et al. 1988,
Sundsfjord et al. 1988).
Disappearance of ANP from the circulation consists of fast and slow components, the
former of which accounts for up to 90% of the removal (Nakao et al 1986, Yandle et
al. 1986). The half-life of ANP at rest is reportedly 16 s to 2.5 min in rats, 1.2 to 4.7
min in humans, and 3 to 4 min in sheep (Nakao et al. 1986, for other references, see
Scarborough 1989 and Ruskoaho 1992, Charles et al. 1996). The half-life of NT-ANP
is about 8- to 10-fold longer than that of ANP (Katsube et al. 1986, Ruskoaho 1992).
The pharmacokinetics of atrial peptides has not been reported in horses and goats.
Ageing has been reported to prolong the the slow-phase disappearance of ANP in
human beings (Ohashi et al. 1987). Despite the rapid half-life of ANP in plasma, its
degradation in blood in vitro is reported to be considerably slower (Scarborough
1989).
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5.1.8 Plasma levels
Basal plasma ANP levels of 3 to 8 pmol/l have been reported in horses (McKeever et
al. 1991a, b, 1992a, McKeever & Malinowski 1999), 2 to 5 pmol/l in 30-day-old
Jersey calves (Wolf et al. 1991), 5 to 21 pmol/l in goats (Olsson et al. 1989,
Kokkonen 1992), 5 to 25 pmol/l in humans (Fyhrquist et al. 1987, Freund et al. 1988,
Itoh et al. 1988, Leppäluoto & Ruskoaho 1990, Baker et al. 1991, Follenius et al.
1992, Cugini et al. 1992, Kool et al. 1994, Nose et al. 1994, Arjamaa et al. 1996), 7 to
29 pmol/l in sheep (Charles et al. 1990, 1993), and 11 to 45 pmol/l in dogs (Goetz et
al. 1986, Metzler et al. 1986, Geer et al. 1988, Hinze et al. 1989, Mäntymaa et al.
1994). In rats, the level has been variously from 20 to 150 pmol/l (Kanervo et al.
1991, Oliveira et al. 1993 Leskinen et al. 1994, Mäntymaa et al. 1994).
Plasma NT-ANP levels in humans and rats are 10- to 50-fold higher than those of
ANP (Sundsfjord et al. 1988, Buckley et al. 1989, Baker et al. 1991, Vuolteenaho et
al. 1992, Leskinen et al. 1994, Arjamaa et al. 1996, Wijbenga et al. 1999). The
difference in basal plasma levels has been explained by a difference in these
peptides’ plasma clearance (Ruskoaho 1992). Because of  a more stable plasma
concentration, NT-ANP has been regarded as a good alternative means to measure
plasma ANP release, especially for diagnostic and prognostic purposes in human
medicine (Kettunen et al. 1994).
Results concerning the effect of age on plasma ANP are controversial. Ageing has
been proposed to increase ANP levels, since, in humans and rats, higher plasma
ANP levels occur in the elderly (Cugini et al. 1992, Wu et al. 1997). Contrary to these
results, however, McKeever & Malinowski (1999) observed no difference in resting
plasma ANP concentrations between old (22 years old) and young (5 years old)
horses. Clark et al. (1990) show in their study that plasma ANP concentrations are
higher in young  women (19-42 years) than in young men (19-45 ). However, ANP
levels in postmenopausal women (64-80) were not greater than in elderly men (62-
86). Decreased ANP content has been reported in the atrial and hypothalamic tissue
of old rats (Wu et al. 1997).
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Elevated plasma natriuretic peptide levels have been associated with various
diseases involving a pressure and/or fluid overload of the heart (Tikkanen et al. 1985,
Fyhrquist et al. 1987, Kettunen et al. 1994, Häggström et al. 1997, Pouta et al. 1997),
and in humans they have been evaluated as prognostic indicators in risk stratification
and as markers of impaired cardiac function (Omland et al. 1996, Muders et al.
1997). Clinical applications of natriuretic peptides for veterinary medicine have been
less well documented.
5.1.9 Circadian rhythm
Circadian rhythm represents a 24-h biological rhythm related to external or internal
cycles, such as daily light-dark cycle, changes in day length or the rest-activity cycle
(Wollnik 1989). Circadian changes in many physiological variables are well known.
Some studies have reported circadian rhythm in plasma ANP in humans (Donckier et
al. 1986, Winters et al. 1988, Bell et al. 1990, Vesely et al. 1990, Cugini et al. 1992,
Sothern et al. 1996) and rats (Kanervo et al. 1991, Oliveira et al. 1993), whereas
others have found in humans no circadian fluctuations (Richards et al. 1987,
Follenius et al. 1992, Chiang et al. 1994, Kool et al. 1994). The report by Wolf et al.
(1991) showed in calves two daily increases in plasma ANP, but these were possibly
due to feeding or to alteration in plasma volume. Quadrupeds are useful subjects for
investigating circadian changes, because the effects of postural changes, which may
complicate the studies in humans (Gillies et al. 1987), do not affect the interpretation.
5.2 Exercising horse
5.2.1 Horse breeds and interbreed differences
Modern horse breeds are derived from different ancestors and comprise three main
types, warm-blooded, half-blooded, and cold-blooded horses, named after the
amount of their heredity from the warm-blooded Arab or Thoroughbred horses. For
example, Standardbred trotters, having their origin in Thoroughbreds, represent
warm-booded horses, which are typically graceful and fast. Half-bred horses are
crosses between Thoroughbreds and heavy horses or native ponies. Cold-blooded
horses are derived from the heavy pre-historic horse of central Europe and are
stocky and slow in movement. The Finnhorse represents an old general type of horse
(regarded as a cold-blooded horse), which was earlier used as a draught horse but
which is nowadays used mainly for trotting and riding. It differs from the
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Standardbred, for example, in haematological variables, muscle fibre composition,
and metabolic response to exercise (Pösö et al. 1983, 1987, Räsänen et al. 1993).
Whether or not interbreed differences exist in plasma atrial peptides remains
unknown.
5.2.2 Types of exercise and exercise testing
As prey animals, the ability of horses to fast and to endure exercise performance has
been essential. With domestication, these features have not been lost and have even
been improved, for example, by development of new breeds such as the
Thoroughbred.
In horse races, horses utilize their characteristic behaviour in running distances
which vary from sprint to endurance. In trotting races the distances are usually from
1600 to 3100 m and require from 2 to 5 minutes. A 3-day event has been regarded
as the most demanding competition for riding horses. It consists of three distinct
parts, one of which is the endurance ride of approximately 35 km, consisting of
different phases with varying velocities, from trot to gallop.
In the past, equine exercise physiology was studied principally in connection with
competitions on a racetrack, but today, treadmill exercise is  most commonly used.
As compared to earlier racetrack tests, exercise tests on a treadmill allow more
accurate standardization of the experiments, e.g., in relation to work intensity and
environmental conditions, and make possible different kinds of sampling during
exercise (Persson 1983, Sexton & Erickson 1990, Sheerman & Morris1990, Marlin et
al. 1994). Moreover, the much greater exercise capacity of horses than of many other
species, for example humans, as well as wide differences in experimental design,
often limit direct comparisons between results for different species. Therefore, only a
few comparisons with other species will be discussed.
5.2.3 Cardiovascular responses
The cardiovascular system responds to exercise with a rapid chronotropic and
inotropic effect, characterised by increases in heart rate, cardiac contractility and
shortening of systole. These are controlled by the autonomic nervous system, which
exerts its effect through a local release of catecholamines from the sympathetic
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nerves or through their release from the adrenal medulla. Increases in heart rate and
contractility of the heart increase cardiac output (Stephenson 1997), which in horses
can achieve a level 2- to 3-fold larger than for ponies and other species (Fregin &
Thomas 1983, Hoppeler 1990, Hopper et al. 1991). Stroke volume increases as a
result of increases in cardiac contractility (Stephenson 1997) as well as in blood
volume (Hopper et al. 1991). At high-intensity, works such as graded exercise to
maximal work intensity (Hopper et al. 1991, McKeever et al. 1993b) and competition
exercise test (CET) (Marlin et al. 1996), which is an equine endurance test consisting
of several exercise phases including two high-intensity phases, cardiac output, right
atrial pressure, and stroke volume have been reported to be elevated. In contrast,
low-intensity steady-state exercise, which increases heart rate and cardiac output,
does not alter stroke volume and right atrial pressure significantly (Hinchcliff et al.
1990). Systemic arterial pressure remains constant during low-intensity exercise, but
during more strenous exercise it increases, irrespective of any reduction in total
peripheral resistance (Hinchcliff et al. 1990, Hopper et al. 1991, Erickson 1993,
McKeever et al. 1993b). Finally, McKeever et al. (1993a, b) in splenectomised and
intact horses provide evidence that the spleen plays an important role in raising right
atrial pressure as well as plasma ANP concentration during exercise.
Heart rate varies in horses from the basal level of 35 bpm up to as high as 250 bpm.
Elevation in heart rate occurs individually, and is linear and related to work intensity
between the heart rate levels of 120 to 210 bpm (Persson 1983, Sexton & Erickson
1990, Hopper et al. 1991, McKeever et al. 1991a, 1993b, Marlin et al. 1996).  At rates
below 120 bpm, parasympathetic withdrawal may affect the changes (Hamlin et al.
1972). If exercise is continued at a constant work intensity in thermoneutral
conditions, the heart rate remains relatively stable after an initial increase (Lindholm
& Saltin 1974, Hinchcliff et al. 1990, Geor et al. 1995). Exposure to exceptional
ambient conditions may affect such cardiovascular responses to exercise as heart
rate, which increases in relation to a rise in ambient temperature and relative
humidity until physiological adaptation has occurred (Geor et al. 1995, 1996).
Total peripheral resistance decreases during exercise (Hinchcliff et al. 1990, Hopper
et al. 1991), indicating that a substantial portion of the body’s skeletal muscle is
involved in exercise (Stephenson 1997). Neural factors, hypoxia, and local
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vasoactive metabolites released by contracting muscles all elicit vasodilatation and
increased blood flow to exercising muscles (Stephenson 1997) and to the skin, when
ambient temperature and relative humidity are increased (Erickson 1993). The study
by Parks and Manohar (1983) showed in ponies a 70- to 76-fold increase in blood
flow to muscles in the limbs during severe exercise, but a reduction of 19% from the
resting values in renal blood flow. It has been experimentally shown that ANP has
vasorelaxant effects (Atlas-Laragh 1987), and its plasma concentration increases in
response to exercise. Thus, it has been speculated that ANP may contribute to
modulation of haemodynamic changes during exercise.
5.2.4 Blood volume expansion
In horses, exercise produces a marked blood volume expansion, due to contraction
of the spleen (Persson 1967, Persson et al. 1973). This occurs rapidly at the onset of
exercise (Persson 1967, McKeever et al. 1993a) under the influence of the
sympathetic nervous system and circulating catecholamines (Davies & Withrington
1973, Ericson 1993). The amount of released blood is dependent on work intensity,
age, sex, and training state, and may be as high as 12 l (Persson 1967, Persson et
al. 1973). The high packed cell volume (PCV) in the splenic blood is related to a high
increase in venous PCV , which in horses may reach 15% (Persson 1967, Hopper et
al. 1991, McKeever et al. 1993a). This is considerably higher than the about 3 to 4%
reported in human beings (Green et al. 1984, Laub et al. 1993). Blood volume
expansion together with muscle movements and increased intrathoracic pressure,
supplements venous return and increases atrial and myocardial fibre stretch and
pressure (Hopper et al. 1991, Erickson 1993), factors involved in release of cardiac
hormones. In addition, in quadrupeds, about 70% of blood volume is at or above the
level of the heart (Melbin & Detweiler 1993), whereas in man with an upright posture
this same amount is below heart level, a fact that may have some importance for
mechanisms related to cardiovascular homeostasis in an exercising quadruped.
5.2.5 Hormonal responses
Exercise increases plasma ANP level in humans (Freund et al. 1988, Vollmer- Larsen
et al. 1989), dogs (Miller et al. 1990, Mäntymaa et al. 1994), rats (Ruskoaho et al.
1989a, Fareh et al. 1992, Mäntymaa et al. 1994), and in horses (McKeever et al.
1991a, b, McKeever & Malinowski 1999). Considering overall knowledge on atrial
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peptides, data in horses have been restricted to only a few investigations. McKeever
et al. (1991a, b) have reported an increase in plasma ANP, which was 4-fold during
endurance exercise at the intensity of 55 to 60% of the HRmax and 6- to 7-fold at
maximal work intensity. In their study (1991a), plasma ANP rose linearly and
proportionally to %HRmax. McKeever et al. (1991a) also reported on a correlation
between ANP and increase in heart rate. Another study by McKeever et al. (1991b)
shows that steady-state submaximal exercise is associated with increases in urine
flow and sodium excretion, as well as in an increase in the plasma ANP
concentration. In horses, the magnitude of the ANP response to exercise has been
reported to be ageing-related (McKeever & Malinowski 1999).
Exercise increases plasma levels of many hormones, such as ACTH (Church et al.
1987, McCarthy et al. 1991), β-endorphin (McCarthy et al. 1991, Erickson 1993),
arginine vasopressin (AVP)( McKeever et al. 1991b, 1992b), cortisol (Church et al.
1987, Erickson 1993), catecholamines (Snow et al. 1992), and the hormones of the
renin-angiotensin-aldosterone system (McKeever et al. 1991a, 1992b). These are
hormones involved in the control of cardiovascular function and fluid balance as well
as with stress and pain relief. Plasma catecholamine concentrations reflect the
response of the sympathetic nervous system. It is still confusing as to whether these
hormones interact with atrial peptides in exercising horses. In addition, a variety of
factors such as mode of exercise, hydration status, training status, diet, environmental
factors, and posture may modulate hormonal responses to exercise (Wade et al. 1989),
but regarding ANP, these relationships are less well known in horses.
5.2.6 Thermoregulation and water balance
Heat is dissipated by conduction, convection, radiation, and evaporation. Increased
cardiac output as well as redistribution of blood flow promote heat transfer to the
body core and its loss to the environment (Erickson 1993). In horses and humans,
differently from other species, the primary mechanism of heat loss is evaporation of
sweat (Carlson 1983), but the respiratory tract also contributes to heat and water loss
(Erickson 1993, Hodgson et al. 1993). Sweating is controlled by both circulating
adrenaline and the sympathetic nervous system, but during heat exposure only the
latter is involved (Snow 1977, Carlson 1983). In a hot environment, sweating is an
important mechanism for heat evaporation and may lead to fluid losses of 10 to
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15 l/h, and to hypovolemia and dehydration (Carlson 1983, Hodgson et al. 1993,
McCutcheon et al. 1995). When the ambient humidity is very high, the vapour
pressure gradient between the body surface and the environment is less, and
evaporation does not occur completely (Carlson 1983, McCutcheon et al. 1995).
When the maximum rate via sweating is exceeded, heat loss via respiration may acts
as a compensatory mechanism (McConaghy et al. 1996) and may reach 15 to 25%
of the heat loss (Guthrie & Lund 1998). Many results suggest that heat exposure,
which can cause significant alterations in fluid balance and cardiovascular function,
can also lead to adaptive changes that attenuate thermal stress and improve thermal
tolerance (Art et al. 1995, Geor et al. 1995, 1996, Harris et al. 1995, Lindinger et al.
1995, Hyyppä et al. 1996, Marlin et al. 1996).
Loss of water and electrolytes through fluid shifts and sweating is the principal means
of reduction in plasma volume caused by exercise (Carlson 1983). In horses, this
decrease is reportedly from 5 to10% following a short submaximal graded exercise
(Persson 1967, McKeever et al. 1993a). ANP is suggested to be involved in fluid
shifts between the intravascular space and interstitium under resting conditions
(Olsson et al. 1994) and during exercise (Nagashima et al. 1995).
5.2.7 Training
Many studies describe in horses physiological responses to training, but a wide
difference in experimental design often limits interpretation of results. In general,
maximum oxygen uptake, blood and plasma volumes, and PCV and other blood cell
variables increase with training, whereas the slope of regression of the submaximal
heart rate on work intensity is less steep (Persson 1967, Rose and Hodgson 1982,
Persson 1983, McKeever et al. 1987, Rose &  Evans 1987, Knight et al. 1991).
Training also results in greater sweat sensitivity but a decrease in total sweat fluid
and in ion losses (McCutcheon & Geor 1996). Few studies have specifically
addressed the issue of endocrine responses and exercise training in horses.
5.2.8 Apprehension and anxiety
Psychogenic factors, such as excitement, anxiety, and fear, result in activation of the
sympathetic nervous system and release of catecholamines which on the other hand
induce cardiovascular and haematological changes (Stewart et al. 1977, Rose &
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Hodgson 1982, Revington 1983, Erickson 1993). Revington (1983) has shown in
Thoroughbreds, for example, significant effects of pre-race excitement on the
haemogram before competition. Whether these psychogenic factors have an effect
on plasma ANP concentration has not been studied in horses.
5.2.9 Recovery
Heart rate decreases sharply within the first minutes after completion of work effort,
but may remain slightly elevated for some time afterwards (Sexton & Erickson 1990,
Geor et al. 1995). The return is dependent on duration and intensity of work effort,
physical working capacity, and on ambient temperature and humidity (Persson 1967,
Carlson 1983, Geor et al. 1995). The level of post-exercise activity may affect
recovery. A report by Lovell and Rose (1995) showed that the initial decrease in
heart rate was faster when the horses stood still after exercise than when they were
walking for the same length of time, but 20 min after exercise the changes were
similar, irrespective of  level of post-exercise activity. Clearance of lactate from
skeletal muscle was more rapid when the horses walked after exercise. Re-
accumulation in the spleen has been reported to be slower than emptying and may
require even more than 1 h if the spleen has been maximally emptied (Persson
1967). Relatively less information is available on the changes during return after
exercise in horses. None of the previous studies in horses have described post-
exercise changes in cardiac peptides.
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6. Aims
The aims of this research were:
1) to determine basal plasma atrial natriuretic peptide levels in the horse and in the
goat, and to assess them in relation to species, breed, sex, age, and physical
condition
2) to study in horses the effects of physical activity on plasma ANP and NT-ANP
concentrations during and after exercise
3) to study exercise-induced changes in plasma atrial peptides in relation to
exercise type and factors associated with their plasma levels or secretion
4) to determine circadian changes in ANP and fluid balance
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7. Materials and methods
7.1. Animals
The animals used were 4 Standardbred horses from the Faculty of Veterinary
Medicine at the Swedish University of Agricultural Sciences, Uppsala, Sweden
(Study IV), and 8 Finnhorses from the Agricultural Research Centre, Equine
Research, Ypäjä, Finland (Studies II, III). The rest of the horses, 12 Finnhorses, 7
Standardbreds, and 6 half-bred riding horses, were owned by private persons
(Studies I, III). The 10 goats were from the Faculty of Veterinary Medicine at the
University of Helsinki, Finland (previously College of Veterinary Medicine) (Study V).
Table 3. Information on animals from original Studies I-V.
All horses were subjected to regular training, and most of them were in condition to
perform in an actual race or 3-day event. The horses were accustomed before the
experiment to running on a treadmill. All the goats were well accustomed to
customary experimental procedures, such as being handled, catheterized, and
sampled, and being restrained while standing in metabolism cages.
Subjecting the animals to any painful stimuli and extra restraint was carefully avoided
to minimize the effect of emotional stress. The experimental designs were approved
by the Ethics Committee for Animal Experiments of the College of Veterinary
Medicine and the National Veterinary and Food Research Institute, the Ethics
Committee for Animal Experiments of the Agricultural Research Centre, and the
Uppsala Local Ethics Committee.
Species Breed/Race  Number of  Females    Males      Age     Weight Number of the
   animals (years ± SD)    (kg ± SD) original study
Horse Finnhorse              20a 9        11b   8.7 ± 2.4   522 ± 46.1       I, II, III
Standardbred 11 4        7c   6.7 ± 3.3   467 ± 50.9         I, IV
Half-bred 6 2        4d   9.5 ± 2.2   539 ± 88.9          III
Goat Finnish 
landrace 10 10        -   6.4 ± 3.1   44.8 ± 8.3          V
a 3 horses used in two experiments; b 7 geldings; c 5 geldings; d 4 geldings
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7.2 Experimental procedures
7.2.1. Exercise tests
7.2.1.1 Submaximal graded exercise test (Standardised Exercise Test = SET;
Studies I, II)
SET was performed on a treadmill with a 3.5° (=6.3%) incline at the Faculty of
Veterinary Medicine of the University of Helsinki. The seven Standardbreds
performed the exercise intervals at speeds of 6, 7, 8, and 9 m/s, and the Finnhorses
at speeds of 4, 5, 6, and 7 m/s (n=8) or 5, 6, 7, and 8 m/s (n=6). The four Finnhorses
performed only three exercise intervals at speeds of 5, 6, and 7 m/s (Study I). These
exercise levels were determined in a preliminary test so that the heart rate of each
horse was ~ 200 bpm at the highest treadmill speed. A steady-state heart rate was
reached within each exercise period.
7.2.1.2 Endurance exercise test with varying velocities (Competition Exercise Test =
CET; Study III)
CET, designed to simulate the endurance test of a 3-day event, was carried out at
the Equine Research Centre in Ypäjä, Finland. Six horses, trained at a mean ambient
temperature of 7 ±  6.7 °C before and during the experiment, performed the test on a
treadmill at a mean temperature of 28 ºC and relative humidity of 58%. CET was
repeated 5 times at 2-week intervals (Trials 1-5), with the exercise always beginning
at the same time of the day. The test included the following phases: a 10-min walk
(1.7 m/s), 10-min trot (Phase A, 3.7 m/s), 2-min gallop (Phase B, 10.0 m/s), 20-min
trot (3.7 m/s), and 10-min walk (1.7 m/s) (Phase X), 8-min canter (Phase D, 8 m/s),
and a 30-min walk (active recovery, 1.7 m/s). The incline of the treadmill was 3º
except for the walk during recovery, which was performed on a flat surface.
7.2.1.3 Submaximal steady-state exercise tests (Study IV)
Two steady-state exercise tests, EXP 1and 2 EXP 2, were carried out at the Faculty
of Veterinary Medicine of the Swedish University of Agricultural Sciences in Uppsala,
Sweden. In EXP 1, four Standardbreds exercised on a flat surface at a constant
treadmill speed eliciting 65 to 70% of maximal heart rate (HRmax). The horses were
studied during normohydration (ad libitum access to water), dehydration (water
withheld for 24 h before exercise), and hyperhydration (12 l of tapwater at body
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temperature through a nasogastric tube during a 10-min period 30 min before
entering the treadmill). In EXP 2, the same horses performed an exercise test during
normohydration at a 3.5° incline at a constant treadmill speed eliciting 90% of HRmax
The tests were performed at 7- to 14-day intervals, in the following order: EXP 1
(normohydration, dehydration, and hyperhydration) and EXP 2 (normohydration).
7.2.1.4 Duration of exercise and exercise distances (Studies I-IV)
Exercise distances, shown in Table 4, were calculated on the basis of treadmill
speed and duration of exercise.
Table 4. Duration of exercise and exercise distances in Studies I-IV.
7.2.2 Experiments on circadian changes (Studies III, V)
In Study III, a 12-h time control experiment was carried out at the Equine Research
Centre in Ypäjä, Finland, in five Finnhorses remaining  in their boxes during the
experiment.
In Study V, circadian variation in ANP, cortisol, and fluid balance was studied at the
Faculty of Veterinary Medicine in Helsinki, Finland, in 10 goats remaining in
metabolism cages during the experiment.
7.2.3 Samples
Blood samples were taken from the jugular vein through a plastic catheter. To avoid
restraining any of the animals, the catheters were inserted about 1 h before each
experiment.  In Study IV (EXP 1), one sample before dehydration was drawn by
venipuncture 24 h before the start of the exercise test.
Na- or K-EDTA was used as an anticoagulant in the sample for plasma hormone
analysis and determination of PCV, and Ca-heparin in another sample for analysis of
plasma concentrations of electrolytes, creatinine, total protein, and osmolality.
    Study I, II   Study IV (EXP 2)   Study IV (EXP 1)       Study III
 8 min   distance 12 min   distance  40 min    distance 60 min    distance
4-7 m/s    2 640 m   7 m/s    5 040 m   6 m/s    14 400 m 1.7-10 m/s    13 740 m
5-8 m/s    3 120 m   8 m/s    5 760 m   7 m/s    16 800 m
6-9 m/s    3 600 m
6 min
5-7 m/s    2 160 m
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Aprotinin, a protease inhibitor, was added in the test tubes in Studies III and IV. Na-
bisulfite was added to test tubes for determination of plasma catecholamines (Study II).
Urine was collected from goats via a Foley retention catheter inserted into the urinary
bladder about 1 h before each experiment (Study V).
Table 5. Blood- and urine-sampling schedule.
7.2.4 Other measurements
Heart rate was monitored during the exercise continuously with a pulse meter
(Studies I, II, III), by obtaining a bipolar ECG (Study IV), or, once horses had left the
treadmill, by phonoendoscopy (EXP 2 in Study IV). During exercise, data were
recorded at the end of each interval or exercise phase.
Respiratory rate was monitored before and during exercise in EXP 2 (Study IV).
Appearance of sweating was observed visually in Study II. Dehydration was
estimated by weight loss (Hyyppä et al. 1996, Study IV).
1. Exercise studies
 Before                       During exercise      After exercise
Studies I, II 8-min graded exercise
    x 2 min, 4 min, 6 min, 8 min 2 min, 5 min, 30 min
60 min
60-min endurance exercise
Study III     x 20 min (trot), 22 min ( gallop), 52 min (trot), 60 min (canter) 60 min, 150 min, 270 min, 
390 min
40-min steady-state exercise 5 min, 15 min, 30 min,  
Study IV     x 10 min, 20 min, 30 min, 40 min 60 min, 120 min, 180 min
12-min steady-state exercise
    x 2 min, 4 min, 6 min, 8 min, 10 min, 12 min 5 min, 15 min, 30 min 
60 min
2. Experiments on time-related changes
 Before                                During        
Study III     x During 12 h
8 samples between 8:30 and 20:00
Study V     x During 24 h
3 h, 6 h, 9 h, 12 h, 15 h, 18 h, 21 h, 24 h
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7. 3 Analytical procedures
7.3.1 Blood and urine analysis
Plasma hormone concentrations were determined by RIA or HPLC. Prior to RIA,
ANP, ADH, ACTH, and β-endorphin were extracted as described in Table 6. NT-ANP
and cortisol were analysed in unextracted plasma.
Table 6. Hormonal analysis and methods.
The methods used for determination of PCV, total plasma protein, and plasma and
urine osmolality, and the concentrations of Na+, K+, and creatinine are shown in
Table 7.
Table 7. Plasma and urine analysis and methods.
In Study IV, the volume of excreted urine was measured. Urine osmolality and
concentrations of Na+, K+, and creatinine were determined (Table 7). These variables
were used for the calculations of urine electrolyte concentrations and renal
clearances as described by Reece (1993).
Parameter Method      Study
ANP RIA  Peninsula Laboratories kit, Belmont, CA, USA; extraction by Geer et al.  (1988)        I-V
NT-ANP RIA  Vuolteenaho et al.  (1985, 1992)       II, III
AVP RIA Vasopressin Rapid kit, Buhlman Laboratories AG, Allschwill, Switzerland;           II, V
extraction by Geer et al. (1988)   
ACTH RIA  Vuolteenaho et al.  (1981, 1992), Ekman et al.  (1994)        II
b-endorphin RIA Vuolteenaho et al.  (1981, 1992), Ekman et al.  (1994)        II
catecholamines HPLC Kokkonen et al.  (Study II)        II
cortisol RIA Cortisol (125I) Radioimmunoassay kit, Orion Diagnostica, Orion, Espoo, Finland;      II, V
Parameter Method        Study
PCV microhaematocrit Adams Microhaematocrit centrifuge, Clay Adams         II, IV, V
Inc., NY, USA and ALC centrifugette 4203, 
Skafte & Claesson AB, Göteborg, Sweden
total plasma proteins light refraction Atago Hand Refractometer, SPR-N, Japan and       II, IV, V
Refractometer, Cambridge Instruments, Buffalo, 
NY, USA
osmolality freezing point Osmette A, Precision Systems Inc., Salsbury,       II, IV, V
(plasma, urine) depression MA, USA and 3W wide range osmometer, 
Advanced Osmometer, Inc., Roebling, Germany  
electrolytes flame photometry Corning Flame Photometry, Evans         II, V
(plasma, urine) Electroselenium Ltd., Halstead, UK 
creatinine filter photometry Kone Specific, Version 3.4, Konelab Oy,          V
(plasma, urine) Espoo, Finland
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7.3.2 Statistical analysis
Multivariate analysis of variance was used to test differences in responses to
exercise between two horse breeds. The time-related data were analysed by ANOVA
for repeated measures. Correlations were tested with regression analysis and by use
of the Pearson correlation coefficient. A paired t-test was used to compare
differences between pre-exercise values. Statistical significance was considered to
be P < 0.05.
8. Results
8.1 Plasma ANP and NT-ANP levels (Studies I-V)
Plasma ANP concentrations in Standardbred and Finnhorse trotters (Study I and II),
and in half-bred riding horses (Study III) were similar, as well as those in plasma NT-
ANP concentrations in Finnhorses (Study II) and half-bred riding horses (Study III).
The mean plasma ANP concentration in horses at rest was 5.7 ± 0.32 pmol/l (n=36),
being 4.2 ± 0.27 pmol/l (n=6) in stallions, 6.5 ± 0.50 pmol/l (n=16) in geldings, and 5.5
± 0.48 pmol/l (n=14) in mares. Plasma ANP was lower in stallions than in geldings (P
< 0.001) and mares (P < 0.05). Plasma NT-ANP at rest averaged 232 ± 20.9  pmol/l
(n=12). The plasma concentration in one stallion was 163 pmol/l, being low
compared to the means of the geldings (263 ± 31.5 pmol/l, n=6) and mares
(208 ± 27.1 pmol/l, n=5). The plasma NT-ANP/ANP ratio was 43 ± 7 (n=11). Plasma
ANP concentrations for the goats (8.7 ± 0.86 pmol/l, n=10) were higher than those for
horses (P < 0.05).
No significant difference in relation to age was observed in basal concentrations of
plasma ANP in horses (n=32) or in goats (n=10), and in those of plasma NT-ANP in
horses (n=12). Age of the horses and goats ranged from 3 to 13 years and from 2 to
8 years, respectively.
8.2 Responses to exercise
8.2.1 Plasma ANP and NT-ANP during and after exercise (Study I)
Plasma ANP concentration was measured in Standardbreds and Finnhorses before,
during, and after SET on a treadmill. Heart rate was recorded before and during
exercise.
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Plasma ANP concentration was similar in both breeds during and after SET. During
the 8-min graded exercise, plasma ANP increased linearly, by 6.7 ± 0.7 pmol/l,
irrespective of physical condition, sex, and age, and peaked at 5 min post-exercise.
At 30 min post-exercise, it was at the same level as at the end of exercise, and 30
min later, still significantly higher than before exercise. The resting heart rate was
similar in both breeds and increased linearly, proportional to work intensity, reaching
a mean level of 204 ±  3 bpm in both breeds.
8.2.2 Atrial peptides in relation to neuroendocrine responses and fluid balance (Study
II)
Plasma concentrations of ANP, NT-ANP, ACTH, β-endorphin, AVP, catecholamines,
and cortisol were determined before, during, and after SET. Plasma concentrations
of total protein and electrolytes, plasma osmolality, and PCV were also measured.
Heart rate was recorded before  and during exercise.
The response of plasma ANP was accordant with that in Study I. NT-ANP increased
significantly during exercise, but reached its maximum level at 30 min after exercise;
30 min later, it was still significantly above the level at the end of exercise. At rest, the
NT-ANP/ANP ratio was 45 ± 9, but it fell significantly within 2 min after the start of
exercise, returning by 1 h after exercise.
The increase in heart rate, up to 205 ± 5 bpm at the end of exercise, was similar to
that in Study I. Plasma catecholamines and PCV increased immediately after the
start of exercise, whereas increases in ACTH, β-endorphin, and AVP occurred more
slowly. Cortisol increased significantly during exercise, but the elevation was only
about 20 nmol/l. Plasma catecholamines and AVP decreased immediately after
completion of exercise, whereas plasma ACTH, β-endorphin, and cortisol remained
elevated longer. ANP correlated with noradrenaline at the onset of exercise. The
increases in plasma ANP and AVP correlated negatively during exercise in four out
of five horses. Changes in ANP did not correlate with those in ACTH, β-endorphin, or
cortisol.
Sweating was mild and began at the late stage of exercise, being most prominent
after exercise. PCV and plasma total protein, electrolytes, and osmolality increased
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during exercise; within 5 min after exercise total protein and electrolytes returned to
baseline, but PCV remained significantly increased. Assuming that exercise-induced
change in PCV is affected by release of blood from the spleen, and that the decrease
in plasma volume following SET is between 6% (Persson 1967) and 10% (McKeever
et al. 1993a), it can be estimated on the basis of PCV that blood volume at the end of
exercise may be expanded by 10 to 20% from the resting level (estimated blood
volume at rest from 70 to 100 ml/kg, Swenson 1993).
8.2.3 Atrial peptides during and after repeated exercise under heat exposure (Study
III)
Plasma ANP and NT-ANP were measured before, during, and after a 60-min
endurance exercise test, which included two high-intensity phases. The changes in
ANP were compared with those of aldosterone, AVP, and total plasma protein
(Hyyppä et al. 1996) and of heart rate and plasma NT-ANP. Heart rate was recorded
before, during, and at 30 min after CET.
No significant differences occurred  in plasma ANP and NT-ANP levels among 5
exercise trials performed at an ambient temperature of +28 °C and a relative humidity
of 58% in horses trained at a mean ambient temperature of + 7°C. ANP and NT-ANP
increased significantly during exercise. In NT-ANP, the main increase occurred
during the low-intensity phases (Phases C-X) including the trot and walk, whereas
ANP remained unchanged during this period. ANP increased the most sharply during
the high-intensity phases (Phases B and D) with the gallop and canter. Within 60 min
after CET, ANP had fallen by 40% from the level at the end of CET, and NT-ANP by
11%. These reached the pre-exercise level 90 min later.
Exercise induced, in all five trials, a similar response in heart rate.  During exercise,
the heart rate varied with exercise intensity, and during the 30 min active recovery,
heart rate decreased by 64%. ANP correlated neither with heart rate nor with plasma
AVP during CET. The trends in mean ANP, NT-ANP, and aldosterone were quite
similar during exercise, but were the opposite after 2.5 h of CET. Plasma protein
increased by 11± 0.7 g/l during exercise, and 6.5 h later was still above the pre-
exercise level. Body weight loss during CET among the five trials averaged 3.1%
(Hyyppä et al. 1967).
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8.2.4 Plasma ANP in relation to hydration status and exercise intensity (Study IV)
Plasma concentrations of ANP and total protein, plasma osmolality, and PCV were
measured before, during, and after exercise, and respiratory rate before and during
exercise. Heart rate was recorded before, during, and after exercise.
In EXP 1 and EXP 2, exercise increased ANP significantly. In EXP 1, plasma ANP
showed a greater increase toward the end of exercise during hyperhydration than it
did during dehydration or normohydration. The area under the plasma ANP
concentration curve was significantly greater when the horses were hyperhydrated
with 12 l of water than when they were dehydrated for 24 h before exercise (3% loss
in body weight). In EXP 2, plasma ANP concentration remained increased for 30
minutes after exercise, whereas in EXP 1, plasma ANP concentration fell by
approximately 30% during the same period. Body weight loss during exercise in EXP
1 was about 3%.
In EXP 1, heart rate before exercise was higher in the hyperhydrated horses than
that in other horses, but in all trials, heart rate remained at a similar level during and
after exercise. Within 5 min after exercise, heart rate decreased by about 30%. In
EXP 2, heart rate decreased by  50% within 5 min, and within 30 min after exercise it
had fallen by about 70%.
8.2.5 Effect of exercise type on plasma ANP and NT-ANP concentrations (Studies I-IV)
Plasma ANP and NT-ANP levels in horses at rest did not differ significantly between
the Studies I-IV (Figs. 1, 2).
SET (Studies I, II) induced an equal increase in plasma ANP in Standardbreds and
Finnhorses, irrespective of training status and of age ranging from 3 to 13 years.
ANP increased during exercise by 7.0 ± 0.7 pmol/l. The rise was similar in the four
Finnhorses, which performed a 6-min SET and started at a higher work intensity level
than the other horses (Study I, Fig. 1). Following a 12-min steady-state exercise
eliciting 90% of HRmax (heart rate about 200 bpm), the increase in plasma ANP in
normohydrated horses was 9.9 ± 3.2 pmol/l (Study IV, EXP 2) and did not differ
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significantly from the increases after SET (Fig. 1). During SET and EXP 2, the rates
of change in plasma ANP were similar (1.7 ± 0.8 pmol/l/2min).
CET elevated ANP by 14.9 ±  2.0 pmol/l, significantly more than SET (Fig.1). A
40-min low-intensity exercise at constant treadmill speed (Study IV, EXP1,
normohydration) raised plasma ANP by 10.9 ± 4.4 pmol/l, which did not differ
statistically significantly from the increases during CET, SET, and EXP2. During EXP 1,
the rate of increase in plasma ANP was 0.7 ± 0.8 pmol/l/2min.
Figure 1. Changes in plasma ANP concentration in Studies I-IV: 1 = 8-min SET
(n=20); 2 = 6-min SET (n=4); 3 = 12-min exercise at 90% of HR max (EXP 2;
n=4); 4 = 40-min exercise at 65-70% of HR max (EXP 1; n=4); 5 = CET (n=6); 6 =
mean 12-h plasma ANP level at rest (n=5). Values significantly different from bar
5 presented as * P < 0.05, ** P < 0.01, and from bar 3 as + P < 0.05.
At 30 min after SET and EXP2, plasma ANP was at the same level as at the end of
exercise or slightly above this, but it fell by approximately 30% after EXP1 (Fig. 1). At
60 min after exercise, the relative decreases in ANP after endurance and short-term
exercise tests were similar.
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Plasma NT-ANP (Fig. 2) increased significantly more during CET than during SET.
The post-exercise changes after CET and SET were significantly different; at 60 min
after SET, NT-ANP rose by 166% from the level at the end of exercise, whereas at
the same time, it fell by 11% after CET.
Figure 2. Effect of exercise type on plasma NT-ANP concentration. 1 = 8-min
SET (n=5); 5 = CET (n=6). Values significantly different from bar 5 represented
as * P < 0.05, ** P < 0.01.
8.2.6 Atrial peptides in relation to heart rate, treadmill speed, workload, and duration
of exercise (Studies I-IV)
During SET, ANP correlated significantly with heart rate and treadmill speed, and NT-
ANP with treadmill speed (Figure 3 a-b, Table 8). During CET, which included the
exercise phases varying from walk to gallop, ANP and NT-ANP did not correlate with
HR and treadmill speed (Study III). In Study IV, individual plasma ANP ranges were
observed during steady-state exercise when the ANP concentrations were plotted
against corresponding heart rate values (Study IV).
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(a) (b)
Figure 3. Scatter plot and regression line (a) ANP vs. heart rate, (b) ANP vs.
treadmill speed in horses (n=20) during a 8-min submaximal graded exercise at
four treadmill speeds from 4 to 9 m/s.
Table 8. Correlations of ANP and NT-ANP in horses with heart rate and  treadmill
speed during submaximal graded exercise.
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       ANP       ANP       NT-ANP      NT-ANP
vs. heart rate vs. treadmill speed    vs. heart rate  vs. treadmill speed
   Correlation     Correlation       Correlation        Correlation 
   coefficient     coefficient       coefficient        coefficient
all horses 
4-9 m/s, n=20 0,533 *** 0,319 **            nt            nt
Standardbreds
6-9 m/s, n=7 0,623 *** 0,726 ***            nt            nt
Finnhorses
5-8 m/s, n=6 0,457 * 0,519 **            nt            nt
Finnhorses
4-7 m/s, n=7 0,461 ** 0,428 *            nt            nt
Finnhorsesa
4-8 m/s, n=6 0,106 0,881 *
a the same Finnhorses as in ANP (2 of those in 5-8 m/s, 4 of those in 4-7 m/s)
* P < 0.05; ** P < 0.01; *** P < 0.001
nt = not determined
36
Table 9. Changes in ANP in relation to duration of exercise, exercise distance,
relative workload, and heart rate in horses undergoing steady-state exercise
(n=4, Study IV).
8.2.7 Plasma ANP in relation to physical condition (Studies I-II)
Table 10 shows that, during exercise, physical condition may affect the heart rate
and plasma ANP responses. A significant difference in plasma ANP concentration
appeared when the concomitant difference in heart rate was 30 to 40 bpm, and the
duration of exercise exceeded 2 min.
Table 10. Changes in heart rate and plasma ANP at treadmill speeds of 5 m/s
and at 6 m/s in Standardbreds (n=7) and in well-trained (n=6) and less-well
trained (n=7) Finnhorses.
Change in ANP   Maximal
     Time   Distance    % HRmax   Heart rate    Treadmill    from 0 min      ANP
     (min)       (m)   level (bpm) speed (m/s)      (pmol/ml)   (pmol/ml)
6 2340 90      201 ± 3      7 or 8       7.2 ± 1.9
10 3900 90      7 or 8       7.5 ± 3.9
12 4680 90      208 ± 3      7 or 8       9.9 ± 3.7 16 ± 6.0
20 7800        65-70      150 ± 5      6 or 7       2.4 ± 7.2
30 11700        65-70      160 ± 7      6 or 7       5.9 ± 3.2
40 15600        65-70      168 ± 3      6 or 7       8.1 ± 5.3 17 ± 4.0
Treadmill speed 5 m/s
  Duration of       HR       ANP
 exercise (min)     (bpm)     (pmol/l)
Finnhorses
well-trained 2    152 ± 6    6.8 ± 1.1
less-trained 4    172 ± 6 §  10.3 ± 1.8 
Treadmill speed 6 m/s
Standardbreds 2    156 ± 2    7.0 ± 0.3
Finnhorses
well-trained 4    166 ± 6    8.2 ± 1.3
less-trained 6    195 ± 5 * * *  12.0 ± 1.8 * * 
A significant difference between the Finnhorses § P < 0.05. 
A significant difference between the less-trained Finnhorses and Standardbreds * * P < 0.01;
 * * * P < 0.001.
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8.3 Cyclic changes in plasma ANP
8.3.1 Daily  variation in ANP in horses (Study III)
In a time-control experiment, between 8:30 h and 20:00 h,  ANP remained
unchanged in 5 Finnhorses. At the individual level the daily variation was very small,
and the horses retained their individual basal plasma levels throughout the
experiment.
8.3.2 Circadian variation in ANP, cortisol and fluid balance in goats (Study V)
During the 24-h period, plasma ANP level ranged from 9.6 ± 0.8 pmol/l to 7.9 ± 0.7
pmol/l. Plasma concentrations of ANP, ADH, total protein, K, urine flow rate and
osmolality, urine concentrations of Na, K, and creatinine, renal electrolyte excretion
and clearances, and haematocrit showed no circadian variation. Circadian variation
was observed in plasma osmolality, and the concentrations of Na and creatinine with
achrophases around 16:00 h and nadirs between 01:00 h and 07:00 h. There was a
small increase in plasma cortisol levels in 6 out of 9 goats at 04:00 h, which,
however, was not statistically significant.
9. General discussion
9.1 Plasma ANP and NT-ANP levels in horses and goats
The molecular structure of ANP in mammalian species is highly conserved, and in
these species, plasma concentrations, determined by existing methods from
extracted plasma, are quite similar. The basal plasma levels in this study, ranging
from 2 to 10 pmol/l, correspond well to the levels reported in healthy horses
(McKeever et al. 1991a, b, 1992a, McKeever & Malinowski 1999) and goats (Olsson
et al. 1989, Kokkonen 1992). Regardless of some physiological differences known to
exist in Standardbreds and Finnhorses (Persson 1967, Pösö et al. 1983, 1987, Kline
& Foreman 1991, Räsänen et al. 1993), the results of this study show that between
horse breeds basal plasma ANP concentration does not differ.
Some hormones may be characterized by species-specific plasma levels, for
example, cortisol with higher plasma concentrations in horses than in goats (Eriksson
et al. 1994, Hydbring et al. 1996, Studies II and V). In ANP, as well, a slightly lower
plasma level in horses than in goats may represent an interspecies difference. On
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the other hand, the higher plasma ANP level of goats was observed only in female
goats (Study IV). Thus, another factor that may explain this concentration difference
is their gender. The study by Clark et al. (1990) shows in humans higher plasma ANP
level in women than in men, and a similar trend, although not as marked, was
observed in horses (Studies I-IV). However, a study in female goats (Olsson et al.
1989) has reported a lower ANP level than that of the present study, indicating that
an analytical approach cannot be left out of consideration. Confirmation of the effect
of gender on plasma ANP remains for further studies, since no other data on gender-
related differences in ANP levels have been reported in horses or in goats.
The results by McKeever & Malinowski (1999) and those of the present study
suggest that, in contrast to humans, in horses basal plasma ANP level does not
increase with ageing (for reviews, see Freund et al. 1988, Cugini et al. 1992). The
difference in age in the present study was not great, but McKeever and Malinowski
compared horses which represented young (age about 5) and old (age about 22)
individuals.
Plasma levels of bioactive compounds are determined by both release and
clearance. In all species studied, ANP99-126, the carboxy-terminus of proANP1-126, is
secreted into the  circulation in equimolar amounts with NT-ANP1-98, the amino-
terminus of proANP1-126  (Vuolteenaho 1985, Itoh et al. 1988, Ruskoaho 1992), but
apparently due to their different elimination, the molar ratio of NT-ANP/ANP in
peripheral plasma is higher than expected on the basis of knowledge on their release
(Arjamaa et al. 1996), an observation made also in this study. The amino acid
sequence of equine NT-ANP1-98 is highly homologous with that of other species
(Richter et al. 1998, Vlasuk et al. 1986), and its basal plasma levels, although
measured only in the present study, seem to be similar to those in humans
(Sundsfjord et al. 1988, Buckley et al. 1989, Baker et al. 1990, Vuolteenaho et al.
1992, Arjamaa et al. 1996). Furthermore, comparable to ANP, levels of plasma NT-
ANP between horse breeds were similar (Studies II, III).
Excitement, anxiety, and fear appear to have an influence on cardiovascular
responses and haematological values, and on plasma hormone concentrations
(Stewart et al. 1977, Rose & Hodgson 1982, Revington 1983, Erickson 1993). The
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animals in the present study were easily trained for the experimental conditions and
seemed to be well accustomed to them. However, the increases in plasma cortisol
and AVP concentrations at the end of Study V may indicate restlessness at this time-
point. These changes were not accompanied by any increase in ANP in goats,
possibly because the goats were physically restrained. Conversely, in one horse the
elevated plasma ANP value at the end of the time-control experiment (Study IV) may
have resulted from increased physical activity and apprehension related to the last
sampling in the box where the horse, between the samplings, was free to move.
Otherwise, no stress of any kind was expected to affect results significantly.
9.2 Changes in plasma ANP and NT-ANP in horses during exercise
Cardiovascular adaptation to exercise is characterized by an increase in cardiac
output as a result of the combined effect of sympathetic and parasympathetic
responses, and the muscle pump and respiratory pump (Stephenson 1997).
Sympathetic activation and catecholamines (Study II) affect cardiac function by
increasing heart rate (Studies I-IV) and force of contraction, as well as by shortening
the duration of systole, which preserves the diastolic filling time (Stephenson 1997).
They also cause contraction of the splenic capsule and vasoconstriction of the
splenic vascular bed, resulting in release of stored blood from the spleen into the
circulation (Davies & Withrington 1973, Erickson 1993) and, thereby, in an marked
increase in PCV (Study II, IV). Increased venous return along with an increase in
ventricular preload assists an increase in end-diastolic volume and stroke volume by
the Starling mechanism (Erickson 1993, Stephenson 1997). Heart-rate levels
obtained in Studies I to IV have been shown in horses to be associated with
significant haemodynamic changes, including an increase in right atrial pressure
(Hopper et  al. 1991, McKeever et al. 1993b, Marlin et al. 1996). Considering the
mechanism related to cardiovascular acceleration during exercise, and that atrial
muscle stretch is regarded as a central regulator of ANP release (Ruskoaho 1992, de
Bold et al. 1996), and is shown to stimulate ANP release from cardiocytes both in
vitro and in vivo (Dietz et al. 1984, Lang et al. 1985), it is not surprising that exercise
raises plasma ANP concentration in horses (McKeever, 1991 a, b, 1993b, Studies I-
IV), as well as in humans (Fyhrquist et al. 1987, Espiner et al. 1986, Somers et al.
1986, Tanaka et al. 1986, Saito et al. 1987, Baker et al. 1991, Vuolteenaho et al.
1992) and in other species (Miller et al. 1990, Mäntymaa et al. 1994). Many factors
40
such as intensity and duration of exercise, training, ageing, and various disease
states have been reported to modulate responses of atrial peptides and other
hormones to exercise (Fyhrquist et al. 1987, Freund et al. 1988, Malinowski &
McKeever 1999). Some of these factors will be discussed in this study.
The results of this study support the view that the principle of the mechanism
controlling ANP release is similar in horses and in other species. However,
physiological pecularities, which, in the horse, are related to excellent aerobic
performance capacity (Erickson 1993), may be of importance in modulating
responses of atrial peptides. For example, exercise-induced blood volume
expansion, which is significant in horses (Persson 1967), and which in them may play
an important role in releasing atrial peptides, remains minor in humans due to the
lower capacity of the human spleen to release blood to compensate for the exercise-
induced decrease in plasma volume (Green et al. 1984, Laub et al. 1993).
Furthermore, it is well known that the horse, due to the large volume of its intestine,
has a great capacity for fluid shift from the gastrointestinal tract (Argenzio 1993), a
phenomenon which in theory may have effect on responses of atrial peptides.
Plasma concentration of a hormone is determined by both release and clearance.
Clearance of atrial peptides involves binding to clearance receptors found in various
organs (Hollister et al. 1989, Gerbes & Vollmar 1990) and involves enzymatic
degradation by neutral endopeptidase or some other enzymes (Gerbes & Vollmar
1990). The potency of degradation is dependent on the tissue and is higher in kidney
than in  liver or lung (Tang et al. 1984). During exercise, visceral blood flow
decreases, whereas blood flow in working muscles increases, as shown by Parks &
Manohar (1983) in ponies and Manohar et al. (1995) in horses. The blood flow in
different organs determines their contribution to the total body clearance of atrial
peptides (Gerbes & Vollmar 1990). Thus, increased circulation, by enhancing
exposure to clearance receptors, may accelerate ANP clearance. No
pharmacokinetic information on atrial peptides in horses has been published, but the
results in Study II led us to assume that the half-life of ANP during exercise is short,
being about 30 times less than that of NT-ANP. For NT-ANP, the kidney is the major
site of degradation (Katsube et al. 1986, Itoh et al. 1988, Sundsfjord et al. 1988), but
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it has not yet been established whether redistribution of blood, or impairment of
glomerular filtration rate (Gleadhill et al. 2000) alter its elimination in horses.
9.3 Changes in plasma ANP and NT-ANP in horses after exercise
The temporal patterns of plasma ANP and NT-ANP suggest that their release
continues to be increased after completion of exercise (Studies I-IV). This differs from
the situation in humans (Fyhrquist et al. 1987, Espiner et al. 1986, Somers et al.
1986, Tanaka et al. 1986, Saito et al. 1987, Baker et al. 1991, Vuolteenaho et al.
1992). However, the different experimental approaches and the marked difference in
exercise capacity between horses and humans make these comparisons
problematic.
The rapid decrease in plasma catecholamines and in heart rate after completion of
exercise (Study II), shows that immediately after completion of exercise, sympathetic
activity of the heart is diminished. However, unlike in humans (Somers et al. 1986),
the heart rate in horses may be slightly elevated more than 30 min after exercise
(Sexton & Erickson 1990, Geor et al. 1995, Study III, IV), but at such low rates it is
unlikely per se to be contributory toward in stimulating ANP secretion. Another factor
involved may be hypervolemia, which returns slowly due to prolonged post-exercise
refilling of the spleen (Persson 1967). Together with fluid shifts into the  intravascular
compartment (Nyman  2001), it may keep venous return high for some time after
exercise. Moreover, the inspiratory pump remains activated in horses after
completion of exercise (Manohar et al. 1994, Study IV) and may contribute to venous
return. Hormonal factors, however, seem not to be responsible for the post-exercise
changes in atrial peptides (Study II). Since these factors only partially explain the
long-lasting increase in atrial peptides, the contribution of other factors, vasoactive or
biochemical, warrants consideration.
As stated, plasma half-lives of ANP and NT-ANP are supposed to differ, which in
addition to continued release of these peptides may explain their temporal pattern
also after exercise (Study II). Since these are the first results that describe post-
exercise changes in atrial peptides in horses, and data on pharmacokinetics of atrial
peptides, as well as on post-exercise haemodynamics and renal function in horses
are limited, the importance of this suggestion remains to be established.
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The more rapid return of plasma NT-ANP after CET than SET (Study II, III) suggests
that dehydration induced by exercise may alter the recovery of atrial peptides. This is
supported by earlier results in horses which have shown that fluid balance has an
effect on the exercise-induced plasma volume response (Hopper et al. 1991, Nyman
2001), which, in turn, has been shown to alter the plasma atrial peptide response
(Hichcliff & McKeever 1998, Study IV). Experimental manipulations that induce
changes in blood volume and pressure have been found to regulate the density of
clearance receptors and plasma ANP level (Ruskoaho 1992). For example, in rats a
short water deprivation was reported to increase ANPC receptor density on
glomerular membranes and to decrease plasma ANP levels (Kollenda et al. 1990). It
is not known whether or how changes in clearance receptor density contribute to
alterations in plasma levels of atrial peptides in horses.
9.4 On factors associated with changes in plasma atrial peptides
9.4.1 Heart rate
Experimental evidence exists that chronotropic stimulation increases ANP release
(for references, see Ruskoaho 1992). Moreover, results in exercising human subjects
(Somers et al. 1986, Tanaka et al. 1986, Fyhrquist et al. 1987, Saito et al. 1987) and
horses (McKeever et al. 1991b, Studies I, II) show that exercise, which accelerates
heart rate, increases plasma ANP concentration proportionally to the change in heart
rate. However, the present results suggest that the increase in heart rate may only
partly explain the variability in plasma ANP values during exercise (Studies I, IV); this
is in agreement with the theory that heart rate per se is not the main stimulus for the
ANP secretion (de Bold et al. 1996). In vivo, for example during exercise, tachycardia
is accompanied by increases in atrial pressure and pulmonary wedge pressure,
which also may explain the elevation in ANP (Walsh et al. 1987, Walsh et al. 1988,
Hinchcliff et al. 1990, Hopper et al. 1991). However, the observation in
splenectomised horses that heart rate and plasma ANP increase in response to
exercise without a simultaneous increase in right atrial pressure (McKeever et al.
1993b) indicates that increased preload alone cannot explain the exercise-induced
changes in ANP. However, these results agree well with the concept that atrial
stretch and atrial wall tension/stress explain the tachycardia-induced stimulation of
ANP (Ruskoaho 1992). The lack of correlation between ANP and heart rate during
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CET (Study III), which is known to increase right atrial pressure (Marlin et al. 1996),
may possibly be explained by bias caused by the fate of ANP after the high-intensity
phase of exercise, comparable to that after SET.
Moreover, a decrease in heart rate after completion of exercise (Sexton & Erickson
1990, Sheerman & Morris 1990, Lovell & Rose 1995, Study IV), and variable
changes in plasma ANP (Studies I-IV) support the view that during recovery primarily
other factors than heart rate account for the post-exercise changes in plasma ANP
concentration.
9.4.2 Blood volume expansion
In horses, exercise causes hypervolemia due to release of splenic blood into the
circulation (Persson 1967, Persson et al. 1973). The emptying of the spleen is related
to workload and occurs rapidly at the start of exertion (McKeever et al. 1993a),
suggested also by the sharp increase in PCV at the early stage of exercise (Studies
II). On the other hand, exercise reduces plasma volume (Persson 1967, Masri et al.
1990, McKeever et al. 1993a, Lindinger et al. 1995, Studies II, IV), as indicated by
the increases in plasma concentrations of total protein and Na as well as in plasma
osmolality. If the decrease in plasma volume is similar to that reported for a
comparable type of exercise (Persson 1967, McKeever et al. 1993a), it can be
estimated that the increase in blood volume during short submaximal graded
exercise was 10 to 20% of total blood volume. This is an amount sufficient  to
increase ANP release, as shown by numerous studies in vitro and in vivo (for
references, see Ruskoaho 1992). In keeping with this, the studies by McKeever et al.
(1991c, 1993b) have shown in horses that the splenic release of blood increases
right atrial pressure and plasma ANP concentration. The relationship between ANP
and right atrial pressure in horses has been subsequently confirmed (Hinchcliff &
McKeever 1998).
Hypervolemia combined with respiratory and cardiovascular adjustments may also
serve as an explanation for increased atrial peptide levels for some time after
exercise. Re-filling of the spleen is known to be slower than its emptying, requiring at
least 20 minutes in horses (Persson 1967), which agrees with the observations in
Study II. Because the post-exercise decrease is faster in total protein than in PCV
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(Sheerman & Morris 1990, Study II, IV) it can be speculated that plasma volume is
restored after exercise and that refilling of the spleen occurs even more slowly than
expected on the basis of PCV values only. The absence of any comparable exercise-
induced volume expansion in humans leads to speculation that this might partly
explain the difference in recovery of plasma atrial peptides between horses and
humans.
9.4.3 Hormones
Interactions of endocrine factors with changes in atrial peptides were examined in
Studies II and III. Noradrenaline was found to correlate with ANP at the the start of
exercise, and it may be involved in ANP release during exercise (Study II), indirectly
through the splenic function or directly, as suggested by experiments in vitro
(Schiebinger et al. 1987). However, the rapid return of catecholamine concentrations
after exercise suggest that they are not involved in ANP release during recovery.
During and after exercise, plasma cortisol concentration increased, reflecting the
changes in plasma ACTH (Study II). Glucocorticoids have been shown to increase
circulating ANP levels and to increase synthesis of both ANP mRNA and ANP
prohormone (Gardner et al. 1986, Argentin et al. 1991). However, because of the
short time-interval of Study II, their effect on plasma atrial peptide level may have
been small. Pressor hormones, such as AVP, increase plasma ANP, either by
increasing atrial distention or by enhancing stretch-mediated ANP release (Ruskoaho
1989b, Ruskoaho 1992), and may have contributed to ANP release Studies II, III).
However, no correlation was observed between ANP and AVP during CET (Study
III), and a negative correlation was observed during SET (Study II), possibly due to
volume load, known to raise plasma ANP concentration and to suppress AVP release
(Schrier et al. 1979, Ruskoaho 1992). Because the endocrine responses do not fully
explain the increased release of atrial peptides during and after exercise, it is
possible that enhanced release of natriuretic peptides following acute stimulation,
which was studied here, is based primarily on mechanical activity of the heart and not
on changes in the hormonal environment; the latter, however,  may become
important during chronic stimulation (de Bold et al. 1996).
45
9.4.4 Heat exposure
Repeated exercise bouts at +28 °C ambient temperature and 58% relative humidity
during 8 weeks did not alter plasma ANP or NT-ANP at rest nor their responses to
exercise in horses not acclimated to heat before the experiment (Study III). Because
the exercise sessions were performed at 2-week intervals, and the horses were
stabled and trained in a cool environment, it seems possible that the benefits of
short-term heat acclimation were lost between the experiments, as is reported to
occur in human beings after 7 days without heat exposure (Armstrong et al. 1991).
Plasma volume expansion, which occurred during the 8-week period (Hyyppä et al.
1996), complicates the estimation of absolute changes in atrial peptides. On the
other hand, the work of Lindinger et al. (1995) suggests that heat and humidity (+30-
34°C/80-85% relative humidity) per se do not alter plasma volume and ion responses
to an acute exercise bout, as compared to cool and dry conditions (+22°C/45-55%
relative humidity).
9.4.5 Fluid balance
The data by Hopper et al. (1991), Hinchcliff & McKeever (1998), and from Study IV
indicate that changes in atrial filling pressure induced by contraction or expansion of
plasma volume alter right atrial pressure and plasma ANP concentration. Furosemide
administration (Hinchcliff & McKeever 1998) and water deprivation (EXP I, Study IV),
which resulted in a decrease in plasma volume as indicated by a decrease in total
plasma protein, attenuated plasma ANP response to exercise. This is consistent with
several other investigations without exercise which have shown reduction in plasma
ANP following fluid loss and decrease in plasma volume (for reviews, see Ruskoaho
1992). Conversely, an increase in plasma volume, which occurs during
hyperhydration (Study IV), increases the response of ANP to exercise, apparently
through increased right atrial pressure (Hopper et al. 1991, Hinchcliff & McKeever
1998).
Sweating affects fluid balance by causing dehydration and decrease in plasma
volume (Carlsson 1983, McCutcheon et al. 1995, 1996). During CET (Study III), loss
in body weight averaged 3.1%, at the same magnitude as reported earlier in a
comparable exercise test in horses exercising in hot, dry (+30°C/40% relative
humidity) and in hot, humid (+30°C/85% relative humidity) ambient conditions (Marlin
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et al. 1996). This figure was slightly, and nonsignificantly greater than the decreases
(2.4%) after CET in cool and dry (+20°C/40% relative humidity) conditions (Marlin et
al. 1996), or than (2.8%) after steady-state endurance exercise (EXP 1 in Study IV).
The nearly similar effect on fluid balance may partially explain the similarity in ANP
responses during endurance exercise in CET and in EXP1.
The results of  Study IV suggest that water balance may modulate plasma atrial
peptide concentrations after exercise, possibly by altering atrial filling pressure. This
is supported by results in Studies II and III, in which the effect of altered water
balance was best seen as a more rapid decrease in atrial peptides after CET, which
caused a marked dehydration, than after SET, which failed to make any considerable
change in water balance. In this respect, plasma NT-ANP appeared to serve as a
better indicator.
9.4.6 Exercise intensity
Increase in plasma ANP concentration has been related to exercise intensity in
horses (McKeever et al. 1991b, Studies I, II, IV) and in humans (for references, see
Freund et al. 1988). Studies I and II show a linear relationship betweeen ANP and
increasing work intensity, the trend observed also in plasma NT-ANP (Study II).
However, reduction in exercise intensity during exercise did reduce plasma atrial
peptide concentrations (Study III), based on the well-known fact that the plasma level
of a hormone is determined by both release and clearance. In addition to effects
during exercise, exercise intensity  was shown to affect the post-exercise return of
atrial peptides to basal plasma levels (Studies I-IV).
9.4.7 Training
Plasma ANP concentration remains unchanged after training periods lasting from 4
to 55 weeks in dogs and rats (Mäntymaa 1994) and in humans (Freund et al. 1987,
Vollmer-Larsen et al. 1989). Available data suggest also that training does not alter
basal levels of ANP, either in endurance-trained subjects or in untrained controls
(Freund et al. 1988), or in endurance athletes after a 4-week training period (Vollmer-
Larsen et al. 1989), or in trained horses after a training period of 8 weeks (Study III),
or in comparison with ANP levels in trained horses with differing training levels
(Studies I, II). Plasma volume expansion following training (McKeever et al. 1987,
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Hyyppä et al. 1996) may complicate estimation of absolute changes in plasma
hormone levels and mask any alteration in their secretion and/or elimination.
Degree of training has an influence on performance capacity and fitness (Persson
1983). It has been shown that training does not change the level of maximal heart
rate but reduces the steepness of slope of the regression line of submaximal heart
rate versus treadmill speed which in well-trained individuals results in a higher work
intensity to reach a heart rate of 200 bpm (Rose & Evans 1987), an observation
made also in Studies I and II. The findings of plasma atrial peptide levels related to
heart rate and work intensity (Studies I, II) and their different correlations between
Standardbreds and Finnhorses as well as between the groups of  well- and less well-
trained Finnhorses support the view that physical condition has an effect on plasma
ANP and NT-ANP responses in horses. To cause a significant difference in plasma
ANP, the difference in increase in heart rate must exceed 30 bpm and the duration of
exercise 2 minutes. As shown in Study I, the effect of  physical condition on test
results can be avoided by standardizing the test on the basis of the heart rate
response and duration of exercise.
9.4.8 Circadian changes
Circadian rhythm is characteristic of many physiological variables. This should be
considered, especially when assessing test results which have a range near the level
of the circadian changes. In horses, secretion of catecholamines, cortisol, and
possibly β-endorpin exhibits circadian rhythmicity (James et al. 1970, Hamra et al.
1993, Irvine & Alexander 1994, Kurosawa et al. 1997, Mehl et al. 1999). In the
present study, exercise-induced responses were much higher than the expected
circadian changes, and thus any influence of circadian variation on responses was
obviously minor. Instead, individual plasma hormone levels characteristic of many
hormones were observed also in the the present study.
Plasma ANP concentration was unchanged in resting horses as well as in goats
standing or lying down for 24 h. These observations support the view that in ANP no
circadian variation with a classic day-night pattern or any other cycle exists. However,
data on circadian variation in ANP is conflicting, since some studies have reported
circadian rhythm in plasma ANP in humans (Donckier et al. 1986, Winters et al. 1988,
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Bell et al. 1990, Vesely et al. 1990, Cugini et al. 1992,  Sothern et al. 1996) and rats
(Kanervo et al. 1991, Oliveira et al. 1993), whereas others have found no circadian
fluctuations (Richards et al. 1987, Follenius et al. 1992, Chiang et al. 1994, Kool et al.
1994). Wolf et al. (1990) reported in calves two daily increases in ANP, but these
were possibly due to feeding or to alteration in plasma volume, and not due to actual
circadian rhythm. On the other hand, the results of Wolf et al. (1990) point out the
involvement of varying factors causing circadian fluctuation in ANP. Consequently, it
can be speculated that also reasons other than circadian variation may explain
circadian changes in humans and rats. For example, postural changes are known to
affect plasma ANP level (Gillies et al. 1987, for other references, see Ruskoaho
1992). Since human being and rats consistently use both vertical and horizontal
postures, unlike quadrupeds, part of the divergency in the results may be posture-
related. In keeping with this, Richards et al. (1987) and Follenius et al. (1992)
demonstrated under controlled experimental conditions the absence of circadian
variation in humans who remained in a recumbent position for 24 h. It is noteworthy
that the horse and goat, used in the present study, are posturally more inactive than
the human and rat and during the experiments were physically inactive (Studies IV,
V), like the humans in the two studies mentioned above. Circadian changes in NT-
ANP are unknown, but considering the secretion mechanism of atrial peptides, it is
probable that the changes are consistent with those for ANP.
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10. Conclusions
Atrial natriuretic peptides, COOH-terminal ANP99-126 (ANP), and the NH2-terminal NT-
ANP1-98  (NT-ANP), are continuously secreted by the heart. On the basis of the
present study in the horse and goat, the following characteristics were shown:
The basal plasma ANP concentration levels in the horse and in the goat were low,
ranging from 1 to 10 pmol/l, and were well comparable to those in healthy individuals
of mammalian species. The basal plasma NT-ANP concentration ranged in horses
from 200 to 300 pmol/l, being approximately 45-fold more than that of ANP. These
results provide no evidence for any inter-breed differences in basal plasma
concentrations of atrial peptides, or for any alteration following physical training. In
mares and geldings, plasma concentrations seemed to be higher than in stallions. No
circadian variation with a classic day-night pattern or any other cycle was observed in
plasma ANP in goats, and during daytime, the plasma ANP concentration was
remarkably constant also in resting horses. The results suggest that in ANP no
circadian rhyhm exists.
Exercise increased the plasma concentrations of ANP and NT-ANP, but at different
temporal rates, most probably due to differences in their plasma half-lives. The
increase in ANP was linear with increasing heart rate and treadmill speed (work
intensity). Exercise increased venous PCV, apparently due to mobilization of the
splenic blood cell reservoir. Consequently, blood volume expansion with muscle
movements and inthrathoracic pressure could be expected partially to explain the
increase in plasma atrial peptides. Plasma concentration of pressor hormones
increased during exercise, but except for the correlation between noradrenaline and
ANP, their interplay with atrial peptides could not be demonstrated.
In horses, exercise induced a long-lasting post-exercise increase in plasma ANP and
NT-ANP, which differs from the observations in human subjects. The increase in NT-
ANP after exercise indicates that the release of atrial peptides is stimulated after
completion of exercise. The role of vasoactive hormones seems to have been minor.
Instead, the elevation in central blood volume appeared to be a possible explanation
for the increase in atrial peptides during early recovery from exercise. Because the
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half-life of ANP seemed to be short and its return slow, it is possible that other factors
were involved, but their nature could not be determined in these studies.
Repeated exercise bouts at 2-week intervals at 28°C and 58% relative humidity did
not alter plasma ANP and NT-ANP resposes in horses stabled and trained in a cool
(7-16°C) ambient temperature.
Difference in water balance, as shown by dehydration, normohydration, and
hyperhydration, was shown to modulate plasma ANP concentration during exercise
and recovery. The results showed also that return of atrial peptides was slower after
short-term submaximal exercise than after endurance exercise, which caused a
marked dehydration.
Exercise intensity was shown to modulate post-exercise changes in plasma atrial
peptides.
In addition, the results provided evidence that differences in performance capacity
and fitness within or between the breeds may be followed by varying responses in
plasma atrial peptide concentration.  Standardization of exercise tests according to
heart-rate response can abolish these differences.
Taken together, the results of these  studies support the theory that an increase in
plasma ANP is related to factors that increase atrial stretch. This is consistent with
the prevailing view and suggests that ANP is involved in regulation of cardiovascular
control and fluid balance during and after exercise in horses.
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